Press Release UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026 Jul 29
Press Release UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103 Jul 15